Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Pollak

Showing results (151-160 of 237) with videos related to

Pageof 24
Sort By:
Breast Cancer Research : BCR|September 20, 2005
Celecoxib analogues disrupt Akt signaling, which is commonly activated in primary breast tumoursJill E Kucab, Cathy Lee, Ching-Shih Chen, et al.
Cancers|November 26, 2022
The NAMPT Inhibitor FK866 Increases Metformin Sensitivity in Pancreatic Cancer CellsMaxime Parisotto, Nhung Vuong-Robillard, Paloma Kalegari, et al.
The Journal of Urology|February 23, 2010
Effect of isocaloric low fat diet on prostate cancer xenograft progression in a hormone deprivation modelJessica C Lloyd, Jodi A Antonelli, Tameika E Phillips, et al.
Experimental Hematology|May 23, 2012
IGF signaling contributes to malignant transformation of hematopoietic progenitors by the MLL-AF9 oncoproteinCatherine E Jenkins, Olena O Shevchuk, Vincenzo Giambra, et al.
Annals of Surgical Oncology|February 7, 2026
Adherence to Endocrine Prevention in Patients with Atypical Hyperplasia and Lobular Carcinoma In Situ: Promising Trends from Real-World Use of Low-Dose TamoxifenNatasha J Stonebanks Cuillerier, Hamda Almarzooqi, Victor Villareal-Corpuz, et al.
Annals of Surgical Oncology|March 13, 2026
ASO Visual Abstract: Adherence to Endocrine Prevention in Patients with Atypical Hyperplasia and Lobular Carcinoma In Situ: Promising Trends from Real-World Use of Low-Dose TamoxifenNatasha J Stonebanks Cuillerier, Hamda Almarzooqi, Victor Villareal Corpuz, et al.
Cancer Research|July 13, 2011
Insulin increases de novo steroidogenesis in prostate cancer cellsAmy A Lubik, Jennifer H Gunter, Stephen C Hendy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2011
Elevated bone turnover predicts for bone metastasis in postmenopausal breast cancer: results of NCIC CTG MA.14Allan Lipton, Judy-Anne W Chapman, Laurence Demers, et al.
Cancer Research|March 5, 2009
Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcomaSofia Avnet, Laura Sciacca, Manuela Salerno, et al.
Endocrine-Related Cancer|June 12, 2012
Stimulation of MC38 tumor growth by insulin analog X10 involves the serine synthesis pathwayHenning Hvid, Sarah-Maria Fendt, Marie-José Blouin, et al.
Pageof 24

Showing results (151-160 of 237) with videos related to

Sort By:
Pageof 24
Breast Cancer Research : BCR|September 20, 2005
Celecoxib analogues disrupt Akt signaling, which is commonly activated in primary breast tumoursJill E Kucab, Cathy Lee, Ching-Shih Chen, et al.
Cancers|November 26, 2022
The NAMPT Inhibitor FK866 Increases Metformin Sensitivity in Pancreatic Cancer CellsMaxime Parisotto, Nhung Vuong-Robillard, Paloma Kalegari, et al.
The Journal of Urology|February 23, 2010
Effect of isocaloric low fat diet on prostate cancer xenograft progression in a hormone deprivation modelJessica C Lloyd, Jodi A Antonelli, Tameika E Phillips, et al.
Experimental Hematology|May 23, 2012
IGF signaling contributes to malignant transformation of hematopoietic progenitors by the MLL-AF9 oncoproteinCatherine E Jenkins, Olena O Shevchuk, Vincenzo Giambra, et al.
Annals of Surgical Oncology|February 7, 2026
Adherence to Endocrine Prevention in Patients with Atypical Hyperplasia and Lobular Carcinoma In Situ: Promising Trends from Real-World Use of Low-Dose TamoxifenNatasha J Stonebanks Cuillerier, Hamda Almarzooqi, Victor Villareal-Corpuz, et al.
Annals of Surgical Oncology|March 13, 2026
ASO Visual Abstract: Adherence to Endocrine Prevention in Patients with Atypical Hyperplasia and Lobular Carcinoma In Situ: Promising Trends from Real-World Use of Low-Dose TamoxifenNatasha J Stonebanks Cuillerier, Hamda Almarzooqi, Victor Villareal Corpuz, et al.
Cancer Research|July 13, 2011
Insulin increases de novo steroidogenesis in prostate cancer cellsAmy A Lubik, Jennifer H Gunter, Stephen C Hendy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2011
Elevated bone turnover predicts for bone metastasis in postmenopausal breast cancer: results of NCIC CTG MA.14Allan Lipton, Judy-Anne W Chapman, Laurence Demers, et al.
Cancer Research|March 5, 2009
Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcomaSofia Avnet, Laura Sciacca, Manuela Salerno, et al.
Endocrine-Related Cancer|June 12, 2012
Stimulation of MC38 tumor growth by insulin analog X10 involves the serine synthesis pathwayHenning Hvid, Sarah-Maria Fendt, Marie-José Blouin, et al.
Pageof 24